Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
<h4>Background</h4> <p>Selective cyclooxygenase-2 inhibitors and conventional non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs) have been associated with adverse cardiovascular (CV) effects. We compared the CV safety of switching to celecoxib vs. continuing nsNSAID th...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Oxford University Press
2016
|